{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T23:36:04Z","timestamp":1768174564100,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972767"],"award-info":[{"award-number":["81972767"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472679"],"award-info":[{"award-number":["82472679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-018"],"award-info":[{"award-number":["2021-I2M-1-018"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-C&T-B-062"],"award-info":[{"award-number":["2021-I2M-C&T-B-062"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-018"],"award-info":[{"award-number":["2021-I2M-1-018"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-C&T-B-062"],"award-info":[{"award-number":["2021-I2M-C&T-B-062"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The prognosis of patients with intrahepatic cholangiocarcinoma (ICC) remains poor owing to the lack of effective targeted therapeutic strategies. Thus, the exploration of the molecular pathogenesis of ICC is urgently required. The cytoskeleton protein, anillin (ANLN), has been reported to contribute to various tumor growth by participating in cytokinesis via RhoA signaling. However, the exact physiological role and potential regulatory mechanism of ANLN in ICC are still not well understood. Based on spindle-related genes, integrated bioinformatic analyses identified ANLN as a potential candidate target for ICC. ANLN was elevated in ICC and predicted worse survival. Mechanistically, VIRMA-mediated m6A modification and IGF2BP3-dependent interaction collectively accounted for the upregulation of ANLN by maintaining its mRNA stability. Furthermore, the combination of ANLN and VIRMA or IGF2BP3 offered a greater predictive value than each marker alone in a large ICC cohort. Functional studies indicated that ANLN was involved in cancer cell proliferation and cell cycle. ANLN knockdown induced cytokinesis failure, DNA damage, and apoptosis in ICC cells. In addition to discovering the crucial role of ANLN in cytokinesis via RhoA activation, we also illustrated that ANLN restrained the Hippo pathway by enhancing the activity of RhoA signaling, which together contributed to ANLN-mediated tumor-promoting effects on ICC. Furthermore, YAP1-TEAD1 transcriptionally activated ANLN, subsequently establishing a self-reinforcing loop between ANLN and Hippo pathway, which was mediated by RhoA signaling as an intermediate regulatory node. Importantly, two clinical drugs, the RhoA inhibitor simvastatin and the YAP1\/TEAD inhibitor verteporfin were determined to be the disruptors of this feed-forward signaling axis, inhibiting ICC tumor growth. These findings reveal the vital function of ANLN in ICC growth and provide promising treatment strategies for ICC.<\/jats:p>","DOI":"10.1038\/s41419-025-08197-5","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:42:05Z","timestamp":1767969725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["VIRMA\/IGF2BP3-mediated ANLN upregulation promotes intrahepatic cholangiocarcinoma growth by forming a positive feedback loop with RhoA\/YAP1\/TEAD1 signaling pathway"],"prefix":"10.1038","volume":"17","author":[{"given":"Jiajun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-405X","authenticated-orcid":false,"given":"Liming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-6318","authenticated-orcid":false,"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"8197_CR1","first-page":"198","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73:198\u2013222.","journal-title":"CA Cancer J Clin"},{"key":"8197_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/cai2.60","volume":"2","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu R, Deng T, Ba Y. Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022. Cancer Innov. 2023;2:36\u201351.","journal-title":"Cancer Innov"},{"key":"8197_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2022.11.005","volume":"78","author":"J Merters","year":"2023","unstructured":"Merters J, Lamarca A. Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma. J Hepatol. 2023;78:652\u20137.","journal-title":"J Hepatol"},{"key":"8197_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05247-0","volume":"13","author":"Y Shi","year":"2022","unstructured":"Shi Y, Cui X, Jiang T, Pan Y, Lin Y, Feng X, et al. The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma. Cell Death Dis. 2022;13:799.","journal-title":"Cell Death Dis"},{"key":"8197_CR5","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1053\/j.gastro.2018.07.010","volume":"155","author":"XM Yang","year":"2018","unstructured":"Yang XM, Cao XY, He P, Li J, Feng MX, Zhang YL, et al. Overexpression of Rac GTPase activating Protein 1 contributes to proliferation of cancer cells by reducing hippo signaling to promote cytokinesis. Gastroenterology. 2018;155:1233\u201349.e22.","journal-title":"Gastroenterology"},{"key":"8197_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s13046-023-02892-x","volume":"42","author":"Y Su","year":"2023","unstructured":"Su Y, Lin H, Yu J, Mao L, Jin W, Liu T, et al. RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma. J Exp Clin Cancer Res. 2023;42:326.","journal-title":"J Exp Clin Cancer Res"},{"key":"8197_CR7","doi-asserted-by":"publisher","first-page":"R135","DOI":"10.1016\/j.cub.2009.12.017","volume":"20","author":"L Zhang","year":"2010","unstructured":"Zhang L, Maddox AS. Anillin. Curr Biol. 2010;20:R135\u20136.","journal-title":"Curr Biol"},{"key":"8197_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.semcdb.2010.08.002","volume":"21","author":"AJ Piekny","year":"2010","unstructured":"Piekny AJ, Maddox AS. The myriad roles of Anillin during cytokinesis. Semin Cell Dev Biol. 2010;21:881\u201391.","journal-title":"Semin Cell Dev Biol"},{"key":"8197_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-cellbio-101011-155718","volume":"28","author":"RA Green","year":"2012","unstructured":"Green RA, Paluch E, Oegema K. Cytokinesis in animal cells. Annu Rev Cell Dev Biol. 2012;28:29\u201358.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"8197_CR10","doi-asserted-by":"publisher","first-page":"R570","DOI":"10.1016\/j.cub.2018.03.045","volume":"28","author":"A Basant","year":"2018","unstructured":"Basant A, Glotzer M. Spatiotemporal regulation of RhoA during Cytokinesis. Curr Biol. 2018;28:R570\u201380.","journal-title":"Curr Biol"},{"key":"8197_CR11","doi-asserted-by":"publisher","first-page":"e34888","DOI":"10.1371\/journal.pone.0034888","volume":"7","author":"P Frenette","year":"2012","unstructured":"Frenette P, Haines E, Loloyan M, Kinal M, Pakarian P, Piekny A. An anillin-Ect2 complex stabilizes central spindle microtubules at the cortex during cytokinesis. PLoS One. 2012;7:e34888.","journal-title":"PLoS One"},{"key":"8197_CR12","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1038\/s41388-022-02274-1","volume":"41","author":"J Chen","year":"2022","unstructured":"Chen J, Li Z, Jia X, Song W, Wu H, Zhu H, et al. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity. Oncogene. 2022;41:3118\u201330.","journal-title":"Oncogene"},{"key":"8197_CR13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.devcel.2019.04.031","volume":"49","author":"S Budnar","year":"2019","unstructured":"Budnar S, Husain KB, Gomez GA, Naghibosadat M, Varma A, Verma S, et al. Anillin promotes cell contractility by cyclic resetting of RhoA residence kinetics. Dev Cell. 2019;49:894\u2013906.e12.","journal-title":"Dev Cell"},{"key":"8197_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41418-022-01104-x","volume":"30","author":"YF Cao","year":"2023","unstructured":"Cao YF, Xie L, Tong BB, Chu MY, Shi WQ, Li X, et al. Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. Cell Death Differ. 2023;30:527\u201343.","journal-title":"Cell Death Differ"},{"key":"8197_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13046-019-1340-7","volume":"38","author":"A Wang","year":"2019","unstructured":"Wang A, Dai H, Gong Y, Zhang C, Shu J, Luo Y, et al. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p\/LASP1 signaling axis. J Exp Clin Cancer Res. 2019;38:347.","journal-title":"J Exp Clin Cancer Res"},{"key":"8197_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1053\/j.gastro.2023.02.043","volume":"164","author":"Y Saito","year":"2023","unstructured":"Saito Y, Yin D, Kubota N, Wang X, Filliol A, Remotti H, et al. A Therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23. Gastroenterology. 2023;164:1279\u201392.","journal-title":"Gastroenterology"},{"key":"8197_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1241-x","volume":"22","author":"D Wang","year":"2020","unstructured":"Wang D, Naydenov NG, Dozmorov MG, Koblinski JE, Ivanov AI. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation. Breast Cancer Res. 2020;22:3.","journal-title":"Breast Cancer Res"},{"key":"8197_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ceb.2019.07.006","volume":"61","author":"S Zhang","year":"2019","unstructured":"Zhang S, Zhou D. Role of the transcriptional coactivators YAP\/TAZ in liver cancer. Curr Opin Cell Biol. 2019;61:64\u201371.","journal-title":"Curr Opin Cell Biol"},{"key":"8197_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41568-023-00579-1","volume":"23","author":"JM Franklin","year":"2023","unstructured":"Franklin JM, Wu Z, Guan KL. Insights into recent findings and clinical application of YAP and TAZ in cancer. Nat Rev Cancer. 2023;23:512\u201325.","journal-title":"Nat Rev Cancer"},{"key":"8197_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","volume":"75","author":"X Song","year":"2021","unstructured":"Song X, Xu H, Wang P, Wang J, Affo S, Wang H, et al. Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. J Hepatol. 2021;75:888\u201399.","journal-title":"J Hepatol"},{"key":"8197_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2022.04.028","volume":"163","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu H, Cui G, Liang B, Chen X, Ko S, et al. \u03b2-Catenin sustains and is required for YES-associated protein oncogenic activity in Cholangiocarcinoma. Gastroenterology. 2022;163:481\u201394.","journal-title":"Gastroenterology"},{"key":"8197_CR22","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ccr.2014.04.016","volume":"25","author":"X Feng","year":"2014","unstructured":"Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, et al. Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated Rho GTPase signaling circuitry. Cancer Cell. 2014;25:831\u201345.","journal-title":"Cancer Cell"},{"key":"8197_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2014.06.029","volume":"158","author":"NJ Ganem","year":"2014","unstructured":"Ganem NJ, Cornils H, Chiu SY, O\u2019Rourke KP, Arnaud J, Yimlamai D, et al. Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell. 2014;158:833\u201348.","journal-title":"Cell"},{"key":"8197_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cub.2007.11.068","volume":"18","author":"AJ Piekny","year":"2008","unstructured":"Piekny AJ, Glotzer M. Anillin is a scaffold protein that links RhoA, actin, and myosin during cytokinesis. Curr Biol. 2008;18:30\u201336.","journal-title":"Curr Biol"},{"key":"8197_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01810-1","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang Y, Patel H, Chen J, Wang J, Chen ZS, et al. Epigenetic modification of m(6)A regulator proteins in cancer. Mol Cancer. 2023;22:102.","journal-title":"Mol Cancer"},{"key":"8197_CR26","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","volume":"83","author":"Z Lin","year":"2023","unstructured":"Lin Z, Li J, Zhang J, Feng W, Lu J, Ma X, et al. Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer. Cancer Res. 2023;83:2187\u2013207.","journal-title":"Cancer Res"},{"key":"8197_CR27","first-page":"19","volume":"9","author":"X Lin","year":"2022","unstructured":"Lin X, Wang F, Chen J, Liu J, Lin YB, Li L, et al. N(6)-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance. Mil Med Res. 2022;9:19.","journal-title":"Mil Med Res"},{"key":"8197_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","volume":"4","author":"Y Yue","year":"2018","unstructured":"Yue Y, Liu J, Cui X, Cao J, Luo G, Zhang Z, et al. VIRMA mediates preferential m(6)A mRNA methylation in 3\u2019UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 2018;4:10.","journal-title":"Cell Discov"},{"key":"8197_CR29","doi-asserted-by":"publisher","first-page":"33516","DOI":"10.1074\/jbc.M504657200","volume":"280","author":"WM Zhao","year":"2005","unstructured":"Zhao WM, Fang G. Anillin is a substrate of anaphase-promoting complex\/cyclosome (APC\/C) that controls spatial contractility of myosin during late cytokinesis. J Biol Chem. 2005;280:33516\u201324.","journal-title":"J Biol Chem"},{"key":"8197_CR30","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1242\/jcs.034785","volume":"122","author":"PP D\u2019Avino","year":"2009","unstructured":"D\u2019Avino PP. How to scaffold the contractile ring for a safe cytokinesis - lessons from Anillin-related proteins. J Cell Sci. 2009;122:1071\u20139.","journal-title":"J Cell Sci"},{"key":"8197_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"FX Yu","year":"2012","unstructured":"Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780\u201391.","journal-title":"Cell"},{"key":"8197_CR32","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/s41556-019-0426-y","volume":"21","author":"R Chen","year":"2019","unstructured":"Chen R, Xie R, Meng Z, Ma S, Guan KL. STRIPAK integrates upstream signals to initiate the Hippo kinase cascade. Nat Cell Biol. 2019;21:1565\u201377.","journal-title":"Nat Cell Biol"},{"key":"8197_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","volume":"24","author":"H Li","year":"2022","unstructured":"Li H, Wu BK, Kanchwala M, Cai J, Wang L, Xing C, et al. YAP\/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis. Nat Cell Biol. 2022;24:373\u201383.","journal-title":"Nat Cell Biol"},{"key":"8197_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56929-0","volume":"16","author":"J Joung","year":"2025","unstructured":"Joung J, Heo Y, Kim Y, Kim J, Choi H, Jeon T, et al. Cell enlargement modulated by GATA4 and YAP instructs the senescence-associated secretory phenotype. Nat Commun. 2025;16:1696.","journal-title":"Nat Commun"},{"key":"8197_CR35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ncb2756","volume":"15","author":"F Calvo","year":"2013","unstructured":"Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry SI, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15:637\u201346.","journal-title":"Nat Cell Biol"},{"key":"8197_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.gene.2014.05.013","volume":"545","author":"NS Pandi","year":"2014","unstructured":"Pandi NS, Manimuthu M, Harunipriya P, Murugesan M, Asha GV, Rajendran S. In silico analysis of expression pattern of a Wnt\/\u03b2-catenin responsive gene ANLN in gastric cancer. Gene. 2014;545:23\u201329.","journal-title":"Gene"},{"key":"8197_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/en.2018-00923","volume":"160","author":"KI Takayama","year":"2019","unstructured":"Takayama KI, Suzuki Y, Yamamoto S, Obinata D, Takahashi S, Inoue S. Integrative genomic analysis of OCT1 reveals coordinated regulation of androgen receptor in advanced prostate cancer. Endocrinology. 2019;160:463\u201372.","journal-title":"Endocrinology"},{"key":"8197_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107512","volume":"210","author":"MT Nguyen","year":"2024","unstructured":"Nguyen MT, Lee GJ, Kim B, Kim HJ, Tak J, Park MK, et al. Penfluridol suppresses MYC-driven ANLN expression and liver cancer progression by disrupting the KEAP1-NRF2 interaction. Pharm Res. 2024;210:107512.","journal-title":"Pharm Res"},{"key":"8197_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W, et al. METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer. 2022;21:60.","journal-title":"Mol Cancer"},{"key":"8197_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2021.08.027","volume":"522","author":"Y Xu","year":"2021","unstructured":"Xu Y, Chen Y, Yao Y, Xie H, Lu G, Du C, et al. VIRMA contributes to non-small cell lung cancer progression via N(6)-methyladenosine-dependent DAPK3 post-transcriptional modification. Cancer Lett. 2021;522:142\u201354.","journal-title":"Cancer Lett"},{"key":"8197_CR41","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255506","volume":"24","author":"N Li","year":"2023","unstructured":"Li N, Zhu Z, Deng Y, Tang R, Hui H, Kang Y, et al. KIAA1429\/VIRMA promotes breast cancer progression by m(6) A-dependent cytosolic HAS2 stabilization. EMBO Rep. 2023;24:e55506.","journal-title":"EMBO Rep"},{"key":"8197_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216598","volume":"584","author":"M Shan","year":"2024","unstructured":"Shan M, Liu D, Sun L, Yang M, He M, Zhang Y, et al. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells. Cancer Lett. 2024;584:216598.","journal-title":"Cancer Lett"},{"key":"8197_CR43","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/cancers16040752","volume":"16","author":"X Zhu","year":"2024","unstructured":"Zhu X, Zhang Y, Bian R, Zhu J, Shi W, Ye Y. ANLN Promotes the Proliferation and Migration of Gallbladder Cancer Cells via STRA6-Mediated Activation of PI3K\/AKT Signaling. Cancers. 2024;16:752.","journal-title":"Cancers"},{"key":"8197_CR44","doi-asserted-by":"publisher","first-page":"490","DOI":"10.62347\/UYQH7683","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu J, Wang S, Zhang C, Wei Z, Han D, Song Y, et al. Anillin contributes to prostate cancer progression through the regulation of IGF2BP1 to promote c-Myc and MAPK signaling. Am J Cancer Res. 2024;14:490\u2013506.","journal-title":"Am J Cancer Res"},{"key":"8197_CR45","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.7150\/ijbs.73570","volume":"19","author":"H Zheng","year":"2023","unstructured":"Zheng H, Cheng ZJ, Liang B, Wang ZG, Tao YP, Huang SY, et al. N(6)-Methyladenosine modification of ANLN enhances hepatocellular carcinoma bone metastasis. Int J Biol Sci. 2023;19:1009\u201323.","journal-title":"Int J Biol Sci"},{"key":"8197_CR46","doi-asserted-by":"publisher","first-page":"9725","DOI":"10.2147\/CMAR.S261828","volume":"12","author":"F Wang","year":"2020","unstructured":"Wang F, Xiang Z, Huang T, Zhang M, Zhou WB. ANLN directly interacts with RhoA to promote Doxorubicin resistance in breast cancer cells. Cancer Manag Res. 2020;12:9725\u201334.","journal-title":"Cancer Manag Res"},{"key":"8197_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111633","volume":"28","author":"L Wang","year":"2025","unstructured":"Wang L, Wang J, Wang N, Wang X, Song M, Zhou Y, et al. ANLN promotes head and neck squamous cell carcinoma progression by upregulating PD-L1 via the ERK-MAPK pathway. iScience. 2025;28:111633.","journal-title":"iScience"},{"key":"8197_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56645-9","volume":"16","author":"YF Cao","year":"2025","unstructured":"Cao YF, Wang H, Sun Y, Tong BB, Shi WQ, Peng L, et al. Nuclear ANLN regulates transcription initiation related Pol II clustering and target gene expression. Nat Commun. 2025;16:1271.","journal-title":"Nat Commun"},{"key":"8197_CR49","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10495-021-01689-7","volume":"26","author":"X Fu","year":"2021","unstructured":"Fu X, Li M, Tang C, Huang Z, Najafi M. Targeting of cancer cell death mechanisms by resveratrol: a review. Apoptosis. 2021;26:561\u201373.","journal-title":"Apoptosis"},{"key":"8197_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03209-y","volume":"11","author":"S Adjemian","year":"2020","unstructured":"Adjemian S, Oltean T, Martens S, Wiernicki B, Goossens V, Vanden Berghe T, et al. Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death. Cell Death Dis. 2020;11:1003.","journal-title":"Cell Death Dis"},{"key":"8197_CR51","doi-asserted-by":"publisher","first-page":"13158","DOI":"10.1073\/pnas.0504145102","volume":"102","author":"WM Zhao","year":"2005","unstructured":"Zhao WM, Fang G. MgcRacGAP controls the assembly of the contractile ring and the initiation of cytokinesis. Proc Natl Acad Sci USA. 2005;102:13158\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8197_CR52","doi-asserted-by":"publisher","first-page":"e1000110","DOI":"10.1371\/journal.pbio.1000110","volume":"7","author":"BA Wolfe","year":"2009","unstructured":"Wolfe BA, Takaki T, Petronczki M, Glotzer M. Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP\/Ect2 RhoGEF complex to initiate cleavage furrow formation. PLoS Biol. 2009;7:e1000110.","journal-title":"PLoS Biol"},{"key":"8197_CR53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12020-024-04145-z","volume":"88","author":"ST Yu","year":"2025","unstructured":"Yu ST, Sun BH, Ge JN, Wei ZG, Zhang ZC, Chen WS, et al. Anillin interacts with RhoA to promote tumor progression in anaplastic thyroid cancer by activating the PI3K\/AKT pathway. Endocrine. 2025;88:211\u201322.","journal-title":"Endocrine"},{"key":"8197_CR54","doi-asserted-by":"publisher","first-page":"11314","DOI":"10.1158\/0008-5472.CAN-05-1507","volume":"65","author":"C Suzuki","year":"2005","unstructured":"Suzuki C, Daigo Y, Ishikawa N, Kato T, Hayama S, Ito T, et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase\/AKT pathway. Cancer Res. 2005;65:11314\u201325.","journal-title":"Cancer Res"},{"key":"8197_CR55","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma S, Meng Z, Chen R, Guan KL. The Hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577\u2013604.","journal-title":"Annu Rev Biochem"},{"key":"8197_CR56","doi-asserted-by":"publisher","first-page":"ra23","DOI":"10.1126\/scisignal.aaa9227","volume":"9","author":"DA Bui","year":"2016","unstructured":"Bui DA, Lee W, White AE, Harper JW, Schackmann RC, Overholtzer M, et al. Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP. Sci Signal. 2016;9:ra23.","journal-title":"Sci Signal"},{"key":"8197_CR57","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1111\/febs.16926","volume":"290","author":"SE Chow","year":"2023","unstructured":"Chow SE, Hsu CC, Yang CT, Meir YJ. YAP co-localizes with the mitotic spindle and midbody to safeguard mitotic division in lung-cancer cells. FEBS J. 2023;290:5704\u201319.","journal-title":"FEBS J"},{"key":"8197_CR58","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1007\/s00210-024-03151-2","volume":"397","author":"N Ara","year":"2024","unstructured":"Ara N, Hafeez A, Kushwaha SP. Repurposing simvastatin in cancer treatment: an updated review on pharmacological and nanotechnological aspects. Naunyn Schmiedebergs Arch Pharm. 2024;397:7377\u201393.","journal-title":"Naunyn Schmiedebergs Arch Pharm"},{"key":"8197_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05970-2","volume":"14","author":"H Chen","year":"2023","unstructured":"Chen H, Yang W, Li Y, Ji Z. PLAGL2 promotes bladder cancer progression via RACGAP1\/RhoA GTPase\/YAP1 signaling. Cell Death Dis. 2023;14:433.","journal-title":"Cell Death Dis"},{"key":"8197_CR60","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.7150\/thno.56604","volume":"11","author":"Q Li","year":"2021","unstructured":"Li Q, Wang M, Hu Y, Zhao E, Li J, Ren L, et al. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer. Theranostics. 2021;11:5794\u2013812.","journal-title":"Theranostics"},{"key":"8197_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.557429","volume":"11","author":"C Wei","year":"2020","unstructured":"Wei C, Li X. The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor. Front Pharm. 2020;11:557429.","journal-title":"Front Pharm"},{"key":"8197_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111186","volume":"119","author":"J Fu","year":"2024","unstructured":"Fu J, Liu W, Liu S, Zhao R, Hayashi T, Zhao H, et al. Inhibition of YAP\/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells. Cell Signal. 2024;119:111186.","journal-title":"Cell Signal"},{"key":"8197_CR63","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1007\/s12033-023-00891-z","volume":"66","author":"XW Wang","year":"2024","unstructured":"Wang XW, Yang ZY, Li T, Zhao XR, Li XZ, Wang XX. Verteporfin exerts anticancer effects and reverses resistance to paclitaxel via inducing ferroptosis in esophageal squamous cell cancer cells. Mol Biotechnol. 2024;66:2558\u201368.","journal-title":"Mol Biotechnol"},{"key":"8197_CR64","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1158\/1078-0432.CCR-24-1762","volume":"31","author":"Y Katayama","year":"2025","unstructured":"Katayama Y, Yamada T, Tanimura K, Kawachi H, Ishida M, Matsui Y, et al. YAP Regulates HER3 signaling-driven adaptive resistance to RET inhibitors in RET-aberrant cancers. Clin Cancer Res. 2025;31:1127\u201341.","journal-title":"Clin Cancer Res"},{"key":"8197_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216635","volume":"583","author":"L Chen","year":"2024","unstructured":"Chen L, Xu G, Song X, Zhang L, Chen C, Xiang G, et al. A novel antagonist of the CCL5\/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation. Cancer Lett. 2024;583:216635.","journal-title":"Cancer Lett"},{"key":"8197_CR66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186291","volume":"135","author":"B He","year":"2025","unstructured":"He B, Zhao R, Zhang B, Pan H, Liu J, Huang L, et al. Endothelial OX40 activation facilitates tumor cell escape from T cell surveillance through S1P\/YAP-mediated angiogenesis. J Clin Invest. 2025;135:e186291.","journal-title":"J Clin Invest"},{"key":"8197_CR67","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.1002\/cam4.5597","volume":"12","author":"N Huang","year":"2023","unstructured":"Huang N, Zhang J, Kuang S, Li Z, Zhao H, Wu J, et al. Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma. Cancer Med. 2023;12:8991\u20139004.","journal-title":"Cancer Med"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08197-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:04:04Z","timestamp":1768165444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08197-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8197"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08197-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of the Cancer Hospital at the Chinese Academy of Medical Sciences. All patients provided informed consent prior to their participation in the study. All animal-related procedures adhered to the internal biosafety and bioethics guidelines of the Institutional Animal Care and Use Committee (IACUC) of the National Cancer Center\/Cancer Hospital. The maximal volume of the tumor was permitted by the ethics committee to be 1000 mm\n                      3\n                      . All tumors in this study were <1000 mm\n                      3\n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"20"}}